Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer
1994

Breast Cancer Cells and Elastase Production

Sample size: 62 publication Evidence: moderate

Author Information

Author(s): J.-I. Yamashita, M. Ogawa, S. Ikei, H. Omachi, S.-I. Yamashita, T. Saishoji, K. Nomura, H. Sato

Primary Institution: Kumamoto University Medical School

Hypothesis

Do breast cancer cells produce polymorphonuclear leucocyte elastase (PMN-E) and how does it relate to cancer progression?

Conclusion

Breast cancer cells produce PMN-E, and higher levels of this enzyme are associated with more advanced disease and poorer survival outcomes.

Supporting Evidence

  • ir-PMN-E was detected in 59 of 62 breast cancer tissue extracts.
  • Patients with high levels of ir-PMN-E had significantly shorter disease-free survival.
  • ir-PMN-E content was significantly higher in advanced cancer stages.

Takeaway

Breast cancer cells can make a special enzyme that helps them spread, and having more of this enzyme means the cancer is likely worse.

Methodology

The study measured PMN-E levels in breast cancer cell lines and tissue extracts using a sensitive enzyme immunoassay.

Limitations

The study had a small sample size of 62 patients.

Participant Demographics

Patients who underwent mastectomy for breast cancer between 1982 and 1984.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication